HIGHLIGHTS
- who: Tengda Wang from the Medical University, China have published the Article: Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments, in the Journal: (JOURNAL)
- what: The study was admitted by the First Affiliated Hospital of Harbin Medical University. ccRCC and adjacent tissue samples were obtained from patients who were aware of the purpose of the study and signed informed consent at the Medical Ethics Committee of First Affiliated Hospital of Harbin Medical University. Biological enrichment analysis was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.